Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomics of human NAFLD: Lack of data reproducibility and high interpatient variability in drug target expression as major causes of drug failures

15 Feb 2024

Abstract excerpt

BACKGROUND AND AIMS: NAFLD is a major disease burden and a foremost cause of chronic liver disease. Presently, nearly 300 trials evaluate the therapeutic efficacy of > 20 drugs. Remarkably, the majority of drugs fail. To better comprehend drug failures, we investigated the reproducibility of fatty liver genomic data across 418 liver biopsies and evaluated the interpatient variability of 18 drug targets. APPROACH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Liver Diseases and Immunity
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38358517
DOI: 10.1097/hep.0000000000000780

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Genomics of human NAFLD: Lack of data reproducibility and high interpatient variability in drug target expression as major causes of drug failuresPMID 38358517Read ↗

SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLDSemantic proximity Read ↗

A robust gene expression signature for NASH in liver expression dataSemantic proximity Read ↗

Clinically Important Alterations in Pharmacogene Expression in Histologically Severe Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

iPSC-derived hepatocytes from patients with nonalcoholic fatty liver disease display a disease-specific gene expression profileSemantic proximity Read ↗

Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatmentSemantic proximity Read ↗

Personalized beyond Precision: Designing Unbiased Gold Standards to Improve Single-Subject Studies of Personal Genome Dynamics from Gene ProductsSemantic proximity Read ↗

Transcriptomic profiling of a multiethnic pediatric NAFLD cohort reveals genes and pathways associated with diseaseSemantic proximity Read ↗

Single-cell metabolic profiling reveals subgroups of primary human hepatocytes showing heterogeneous responses to drug challengeSemantic proximity Read ↗

Transcriptomic mapping of the inter-individual variability of cellular stress response activation in primary human hepatocytesSemantic proximity Read ↗

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and TransportersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.